巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Athersys

    ATHX
    1.610
    0.010
    0.62%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Athersys - 延遲價格・最後更新於 29/09 12:00
    最高位
    1.650
    最低位
    1.530
    開市價
    --
    前收市價
    1.620
    成交量(千)
    20.85
    成交額(百萬)
    0.28
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    491.23
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    35.500 - 1.130
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Athersys
    證券代碼
    ATHX.US
    所屬板塊
    Biotechnology
    公司業務
    Athersys Inc is a biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is an unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.
    發行量
    305109746
    公司總部
    3201 Carnegie Avenue
    公司網址
    https://www.athersys.com
    公司電郵
    ir@athersys.com
    公司電話
    +1 216 431-9900

    美股異動 | Athersys(ATHX.US)盤前跌超5% 有機構下調其目標價至0美元

    格隆匯·
    美股異動 | Athersys(ATHX.US)盤前跌超5% 有機構下調其目標價至0美元

    美股異動 | Athersys(ATHX.US)盤前跌超5% 有機構下調其目標價至0美元

    格隆匯·
    美股異動 | Athersys(ATHX.US)盤前跌超5% 有機構下調其目標價至0美元

    關於

    Athersys(ATHX.US)所屬的行業板塊為Biotechnology。
    Athersys Inc is a biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is an unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.
    詳細公司背景可參考: https://www.athersys.com